William Conkling - Jun 2, 2025 Form 4 Insider Report for Protara Therapeutics, Inc. (TARA)

Role: Chief Commercial Officer
Signature: /s/ William Conkling
Stock symbol: TARA
Transactions as of: Jun 2, 2025
Transactions value $: $0
Form type: 4
Date filed: 6/4/2025, 04:10 PM
Previous filing: Apr 24, 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
CONKLING WILLIAM	Chief Commercial Officer	C/O PROTARA THERAPEUTICS, INC., 345 PARK AVENUE SOUTH, 3RD FLOOR, NEWARK	/s/ William Conkling	2025-06-04	0001852018

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TARA	Common Stock	Award	$0	+50K		$0.00	50K	Jun 2, 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TARA	Stock Option (Right to Buy)	Award	$0	+200K		$0.00	200K	Jun 2, 2025	Common Stock	200K	$3.30	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one third installments on the first, second and third anniversaries of June 2, 2025.
F2	25% of the shares vest on the one year anniversary of June 2, 2025 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date.